Cargando…
Editorial: Could reverse remodeling be a novel treatment goal of pulmonary hypertension?
Autor principal: | Yamauchi-Takihara, Keiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese College of Cardiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277941/ https://www.ncbi.nlm.nih.gov/pubmed/30534318 http://dx.doi.org/10.1016/j.jccase.2014.02.004 |
Ejemplares similares
-
Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy
por: Ishihara, Satomi, et al.
Publicado: (2018) -
Interferon Therapy Exacerbated Pulmonary Hypertension in a Patient with Hepatitis C Virus Infection: Pathogenic Interplay among Multiple Risk Factors
por: Tsuchiya, Hiromi, et al.
Publicado: (2017) -
BET in Pulmonary Arterial Hypertension: Exploration of BET Inhibitors to Reverse Vascular Remodeling
por: Dai, Zhiyu, et al.
Publicado: (2019) -
Polycythemia Vera Associated with Pulmonary Hypertension and Diffuse Large B-Cell Lymphoma: A Case Report
por: Kameda, Satoshi, et al.
Publicado: (2021) -
Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis
por: Miyawaki, Hiroshi, et al.
Publicado: (2019)